Renal Research Institute, New York, New York; †Beth Israel Medical Center, New York, New York 10128, USA.
ASAIO J. 2011 May-Jun;57(3):219-24. doi: 10.1097/MAT.0b013e3182178c59.
Dialysate regeneration by sorbents is an alternative to conventional single-pass dialysis. Little is known about the capacity of sorbents to clear dialysate of “middle molecules” and protein-bound uremic toxins. We studied p-cresol sulfate (PCS) and β-2-microglobulin (β2M) removal from dialysate by a sorbent: 1. PCS (40 mg PCS dissolved in 4 L of fresh dialysate) was recirculated through a sorbent cartridge (SORB Technology, Inc.) for analysis of PCS removal. 2. Spent peritoneal dialysate was recirculated on the “blood” side of a high-flux dialyzer. On the “dialysate” side of the membrane, bicarbonate dialysate was recirculated through a sorbent cartridge. β2M was measured in both streams. Two results are of particular importance for the use of regenerated fluid in chronic dialysis: 1. PCS was virtually completely removed from the dialysate. On average, PCS concentration was reduced to 1.4% of the starting concentration after 60 minutes. PCS extraction across the sorbent was nearly complete at any time. 2. β2M was on average reduced to 14.3% of the starting concentration after 60 minutes. Postsorbent concentrations were consistently below the validated range of the test method. We conclude that PCS and β2M are efficiently removed from the dialysate by commercially available sorbent technology. Spent peritoneal dialysis fluid can be cleared of β2M when circulated against sorbent-regenerated dialysate using a high-flux membrane.
吸附剂再生的透析液是传统单通透析的替代方法。对于吸附剂清除透析液中的“中分子”和蛋白结合尿毒症毒素的能力,我们知之甚少。我们研究了吸附剂对 p- 对甲酚硫酸盐(PCS)和β-2- 微球蛋白(β2M)从透析液中的清除:1. 将 40mgPCS 溶解在 4L 新鲜透析液中,将 PCS (40mgPCS 溶解在 4L 新鲜透析液中)循环通过吸附剂筒(SORB Technology,Inc.)以分析 PCS 去除情况。2. 将用过的腹膜透析液在高通量透析器的“血液”侧循环。在膜的“透析液”侧,碳酸氢盐透析液通过吸附剂筒循环。在两个流中都测量了β2M。对于在慢性透析中使用再生液,有两个结果特别重要:1. PCS 从透析液中几乎完全去除。平均而言,在 60 分钟后,PCS 浓度降低到起始浓度的 1.4%。在任何时候,吸附剂上的 PCS 提取都几乎完全。2. 60 分钟后,β2M 平均降低到起始浓度的 14.3%。吸附后浓度始终低于测试方法验证的范围。我们得出结论,商业上可用的吸附剂技术可有效去除透析液中的 PCS 和β2M。当使用高通量膜将用过的腹膜透析液循环通过吸附剂再生的透析液时,可以清除β2M。